Approach to epilepsy POWER POINT---EDITED.ppt
-
Upload
vipul-nagnesia -
Category
Documents
-
view
233 -
download
0
Transcript of Approach to epilepsy POWER POINT---EDITED.ppt
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
1/41
Approach to epilepsy
evaluation and treatment of seizuresin ER
history of epilepsy or first seizure e.g.
poorly controlled epilepsy comesafter a seizure and has recovered to
normal interictal stateAggressive lumbar punture repeatscans may not be necessary
http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html -
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
2/41
.
You cant attribute fever, focal
weakness, or altered awareness to
the post-ictal state
may signal new or deteriorating
disorders
Individuals with epilepsy are still
human and can any other disease
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
3/41
.emergency EEG is useful in:-
to distinguish successful resolution of
convulsive status epilepticus from a
conversion to subtle status epilepticus
to rule out seizures as a cause of unusualbehavior or movements
If muscle and movement artifacts present
difficulty in interpreting these events, video-
EEG can be extremely useful
http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html -
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
4/41
Emergency neuroemaging CT or
MRI
Any change in the patients seizure
pattern or type
prolonged postictal confusion or
worsening mental status. patients
who have epilepsy with recurrent
seizures whenever the physician
suspects a serious structural lesion.
http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html -
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
5/41
e.g
new focal deficits
persistent altered mental status (with or withoutintoxication with alcohol other substance)
fever
recent trauma
persistent headache
vomiting
history of cancer
history of anticoagulation
suspicion of acquired immunodeficiency syndrome(AIDS)
http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html -
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
6/41
.
If an MRI scan --seizure protocol
thin coronal cuts through the
amygdala,
hippocampus,
mesial temporal regions,
T1, T2, and FLAIR pulse sequences
http://professionals.epilepsy.com/page/emergency_approach.htmlhttp://professionals.epilepsy.com/page/emergency_approach.html -
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
7/41
Neck immobilization
Spinal immobilization in individuals
after seizures is rarely necessary. In
one retrospective study, 1,656 cases
over a 10-year period were reviewed,and no spinal injuries were found.[25]
http://professionals.epilepsy.com/page/emergency_ref.htmlhttp://professionals.epilepsy.com/page/emergency_ref.html -
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
8/41
Communication
Contacting the patients treating
physician is vital to good quality and
continuity of care.
In one study, AED therapy was
altered by the ED in nearly 20% of
epilepsy patients who were evaluated
and discharged from an ED,
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
9/41
Driving, swimming, cooking
alone, working in risky areas
e.g.moving machines, scaffoldReview issues of compliance with the
patient, and inform him or her about
the state laws that pertain to driving.
Some countries by law you have to
inform Department of Motor Vehicles
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
10/41
, Figure: EEG demonstrating a single generalized
polyspike-and-wave in second 2 and brief burst of
generalized spike-and-waves in second 7
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
11/41
What is strong of evindence of drug
resistant epilepsy
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
12/41
Status epilepticus is a neuologic
.
Status epilepticus is a neurologicemergency associated
with high mortality and long-termdisability. Recent advances
in our understanding of thepathophysiological
mechanisms involved in the initiationand perpetuation of
seizure activity have revealed thatstatus epilepticus is a
dynamic and evolving process.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
13/41
,
PATHOPHYSIOLOGY
Status epilepticus represents a failure ofinherent cellular
mechanisms to prevent sustained seizureactivity.22 These
mechanisms are believed to fail secondaryto either persistent
excitation of a cellular focus or ineffectiveinhibition of
sustained seizure activity.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
14/41
,
Results of experiments on brain slice
preparations suggest that sustained seizureactivity
requires the development of a reverberating circuit
betweenentorhinal and hippocampal structures. #Thisappears
to occur as an all-or-none phenomenon,# with
seizuresbecoming self-sustaining after 15 to 30 minutes of
stimulation.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
15/41
,
These findings suggest that SE involves both anactivation
and a maintenance phase.24 Activation may beinitiated
by the presence of excessive excitatorystimulation. This
concept was supported by the clinical observationof the
development of SE in individuals after they
inadvertentlyingested domoic acid, an analogue of anexcitatory amino
acid.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
16/41
,
Induced seizures may be sustained byfailure of -
aminobutyric acid (GABA)-mediated
suppression of anactivated focus. This resistance maydevelop through seizure-
induced formation of varying isoforms of
the GABAtype A (GABAA) receptor in thehippocampus.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
17/41
,
Alternatively, SE may be perpetuatedby sustained Nmethyl-
D-aspartate (NMDA)-mediated
neuronal stimulation.27 In animal models, SE developed asensitivity toNMDA
simultaneously with the developmentof progressive GABAAresistance.28,29
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
18/41
,
It is believed that earlypharmacological administration
of medication leads to termination of
seizures withmuch smaller doses and withsubsequent less risk to the
patient than would be required ifseizures were allowed to
progress.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
19/41
.
important consideration in thetreatment of SE
is the immediate need for EEG
monitoring. Electrographicseizure activity has been reported tocontinue in up to 15%
of patients whose overt clinicalseizures are pharmacologically
controlled.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
20/41
.
out-of-hospital administration ofbenzodiazepines, a
randomized double-blind trial comparingintravenous (IV)
diazepam (5-10 mg) or lorazepam (2-4 mg)In many circumstances, IV access
may be unavailable during emergencytransport; in
these settings, rectal or intramuscularadministration of
benzodiazepines may be effective.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
21/41
,
Initial management of SE follows the principles of basic
life support.2,8 The first priority is ensuring an adequate
airway. Most patients with SE maintain adequate ventilation
as long as an adequate airway is present.# Oral or
nasopharyngeal devices supplemented with oxygen
deliveredvia a nasal cannula or bag mask ventilation are usually
adequate to maintain oxygenation and avoid hypoxemia;
prolonged seizures, however, lead to loss of pharyngeal
tone and increase the risk of aspiration. The timing of oral
or nasal tracheal intubation is a clinical decision, but mostpatients who receive large doses of benzodiazepines or
other sedative medications will require mechanicalventilatory support.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
22/41
.
Intubation can be problematic for patients with GCSE
who may require neuromuscular blockade. If neuromuscular
blockade is required, a short-acting nondepolarizing
agent such as rocuronium bromide is preferred. If there is a
possibility of rhabdomyolysis, succinylcholine chloride
should be avoided because of potentialhyperkalemicinduced
cardiac arrhythmias. Adequate peripheral IV access
is needed to provide drugs and fluid resuscitation.
Central access may be required if inotropes are needed for
blood pressure support.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
23/41
,
All patients should have continuous
pulse oximetry and
electrocardiographic monitoring. Of
Cardiac arrhythmias
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
24/41
.
sudden death can occur in SE, presumably secondary to
sympathetically mediated cardiac damage Hypoxemia is
common and has many etiologies including apnea, airway
obstruction, aspiration, and neurogenic pulmonary
edema. Frequent monitoring of blood pressure and urinary
output is crucial because hypotension is a commonadverse effect of several of the medications used to control
seizures. More invasive monitoring may be required if the
patient becomes hemodynamically unstable. Continuous
EEG monitoring is required in all patients who receive
long-term neuromuscular paralytic agents, have a prolongedpostictal period, are being treated for refractory SE
(RSE), or have atypical features to their seizures suggestive
of pseudoseizures.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
25/41
,
Routine laboratory evaluation includes serum electrolytes,glucose, magnesium, calcium, liver function tests,
complete blood cell count, creatine kinase, toxicology
screen, and antiepileptic medication levels. Treatment
should be based on the findings of this evaluation. A bedside
glucose level should be attained as soon as possibleand 100 mg of thiamine and 50 mL of 50% glucoseadministered
if hypoglycemia is present.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
26/41
,
In GCSE, a metabolicacidosis inevitably is found and reflects sustained muscular
activity. This acidosis is self-correcting once seizures are
controlled and rarely requires treatment. Arterial blood gas
testing may reveal hypoxia or a respiratory acidosis that
requires ventilatory support.Hyperthermia augments
neuronal damage due to sustained seizure activity and
should be treated aggressively with active cooling
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
27/41
.
A full diagnostic evaluation should be initiated on thepatients arrival at the emergency department. Pertinent
historical features include any recent change in medication,
alcohol or drug use, previous epilepsy, or neurologic insult.
If witnessed, a description of the onset and initial features
of the seizure may be helpful. In the absence of a knownseizure disorder, computed tomography of the head should
be performed once the patient is stabilized and seizures are
controlled. The threshold for obtaining cerebrospinal fluid
should be low.
MPsUrine toxic screen
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
28/41
,
Benzodiazepines.
Benzodiazepines are an antiepilepticmedication used for the initial treatment of SE. They
are a class of drugs that act at the GABAA receptor.Stimulation
of this subunit leads to inhibition of neural transmission
through hyperpolarization of the resting cell membrane.This is accomplished through the GABA-induced
opening of chloride channels, which allows for intracellular
chloride influx.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
29/41
.
At higher concentrations, benzodiazepines reduce repetitiveneuronal firing by a mechanism
similar to that of phenytoin and carbamazepine.
Diazepam achieves higher brain concentrations and has a
slightly faster onset of action,
although , Because of high lipidsolubility, diazepam is redistributed rapidly to peripheral
fat stores. This property limits its clinical effectiveness to
only 20 to 30 minutes and accounts for its large relapse
rate
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
30/41
.
Phenytoin and Fosphenytoin.
Phenytoin (5,5-diphenyl-2,4-imidazolidinedione) is a barbiturate-like drug that
is effective in controlling seizure activity. It limits the
repetitive firing of action potentials through the slowing of
the rate of recovery of voltage-activated sodium channels.
Phenytoin is formulated with propylene glycol and ethanoland is adjusted to pH 12 with sodium hydroxide. It is highly
protein-bound with only the free portion being metabolically
active. Maintaining appropriate drug levels can be
problematic because of multiple drug interactions and the
saturable pharmacokinetics of hepatic metabolism andprotein binding.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
31/41
.
The loading dose of phenytoin for SE is 20 mg/kg innonglucose-containing solutions administered at a maximal
rate of 50 mg/min
A gram of phenytoin is commonly
given, but this is an insufficient loading dose for
most adult patients.In the absence of clinical effect, an
additional 10 mg/kg is given because many patients may
require serum levels of approximately 25 to 30 gm/mL to
achieve seizure control.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
32/41
. phenytoin
adverse effects SE are cardiovascular, includinghypotension, QT prolongation,
cardiac dysrhythmias. Most can be attenuated
by reducing the infusion rate. The effects are attributable to
a direct effect of both the medication and the propylene
glycol used as a diluent.14The most problematic adverse effect is severe tissue
reaction that can occur with extravasation of phenytoin into
adjacent tissue. The purple glove syndrome, a variant of
this reaction, occurred in up to 5.9% of patients in one
Mayo series.57
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
33/41
.
Despite this rapid administration, it is
unclear whether
fosphenytoin controls seizures faster
than phenytoin.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
34/41
.
Phenobarbital.
Phenobarbital is a barbiturate thatprevents seizure activity by increasing GABAA-mediated
cellular inhibition
third-line drug in algorithms designed to
treat SE because of its serious adverse effect profile.14
Phenobarbital profoundly depresses respiration andconsciousness
level with a half-life of more than 48 hours. In
addition, it causes severe hypotension secondary toperipheral
vasodilation and decreased cardiac contractility.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
35/41
RECENT ADDITION
IV Valproic Acid and Other Medications.
Valproicacid is a short-chain fatty acid with anticonvulsant properties.
similar to phenytoin in that
prolonged recovery of
activated voltage-gated sodium channels. Other
mechanismson
neuronal calcium channels or through its effects on GABA
metabolism.55 Valproate has been used previously
Rectal form
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
36/41
NO LONGER USED
Lidocaine hydrochloride and
paraldehyde have been
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
37/41
nonpharmacological
Including
vagal nerve stimulation,
plasmapheresis,
electroconvulsive therapy,
and surgical resection of cortical
tissue,
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
38/41
. refractory status epilepticus
require treatment with anesthetic
doses of benzodiazepines,
short-acting barbiturates, or propofol.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
39/41
.
, isoflurane, a volatile
Ketamine hydrochloride in controlling
recalcitrant seizures
neuroprotective because it
simultaneously controls seizures
and blocks glycine-activated NMDA
receptors.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
40/41
,AIM
20 minutes of treatment and did not
return for at least 40
minutes.
-
7/27/2019 Approach to epilepsy POWER POINT---EDITED.ppt
41/41
THE FUTURE
We need :-
may involve both a GABA agonist to
prevent seizures and an
NMDA antagonist to prevent neuronal
damage